26 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Feb 24
Maravai Lifesciences Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
Commercial Officer, recognized on the Healthcare Technology Report’s list of Top 25 Women Leaders in Biotechnology of 2023.
"We closed out a challenging 2023
424B4
c4hxay3ot8 l5wakoe
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
jlqsnqjd6 un
26 Aug 21
Draft registration statement
12:00am
DEF 14A
p7lbwnbpoc8
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
5cq8bd
9 Apr 21
Preliminary proxy
4:16pm
424B4
37hcz2 6mkuiv9
9 Apr 21
Prospectus supplement with pricing info
4:02pm
CORRESP
r6rqh219r0oghrjx79nm
5 Apr 21
Correspondence with SEC
12:00am
DRS
307j5q
25 Mar 21
Draft registration statement
12:00am
10-K
yypkzti
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
85i4f4d 3bg39
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
6gftg8u4jgz
23 Nov 20
Prospectus supplement with pricing info
4:36pm